找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Adult and Pediatric Neuromodulation; Jason P. Gilleran,Seth A. Alpert Book 2018 Springer International Publishing AG, part of Springer Nat

[復制鏈接]
樓主: 警察在苦笑
31#
發(fā)表于 2025-3-26 23:58:04 | 只看該作者
32#
發(fā)表于 2025-3-27 02:11:42 | 只看該作者
https://doi.org/10.1007/978-1-4302-2794-6nt option that has been studied extensively in patients with severe and refractory OAB. SNM significantly reduces urgency, frequency, and incontinence while also improving quality of life. Although SNM is not currently indicated for the treatment of OAB symptoms due to neurologic disease, recent lit
33#
發(fā)表于 2025-3-27 06:53:50 | 只看該作者
Interfacing to the Operating System, emptying can be found. This poses unique challenges to treating clinicians, and until recently, management was limited to physical therapy, assisted emptying with intermittent catheterization, foley catheter placement, or urinary diversion. Neuromodulation, in multiple forms, offers a minimally inv
34#
發(fā)表于 2025-3-27 10:11:31 | 只看該作者
Interfacing to the Operating System,tion system. PNE has been used since 1997 for the initial test phase and maintains many advantages. Advances in lead wire technology have increased the frequency of the initial test phase being performed in the operating room; however, this is an expensive and labor intensive technique. PNE is an of
35#
發(fā)表于 2025-3-27 14:14:42 | 只看該作者
36#
發(fā)表于 2025-3-27 20:27:14 | 只看該作者
https://doi.org/10.1007/978-1-4302-2794-6ctive bladder, non-obstructive urinary retention, and fecal incontinence. Since its introduction in the early 2000s, it continues to experience a “coming of age”. As a result, pudendal neuromodulation is perhaps settling into the unique role as an alternative approach to those who have failed sacral
37#
發(fā)表于 2025-3-27 22:57:07 | 只看該作者
38#
發(fā)表于 2025-3-28 05:21:57 | 只看該作者
39#
發(fā)表于 2025-3-28 09:25:25 | 只看該作者
Interfacing to the Operating System,tibial nerve at the ankle. PTNS is a minimally invasive technique that requires no permanent lead or implanted stimulator. It is currently approved by the United States Food and Drug Administration (FDA) for the treatment of overactive bladder (OAB) and its associated frequency, urgency, and urgency
40#
發(fā)表于 2025-3-28 14:01:10 | 只看該作者
 關于派博傳思  派博傳思旗下網站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網 吾愛論文網 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經驗總結 SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網安備110108008328) GMT+8, 2025-10-6 12:30
Copyright © 2001-2015 派博傳思   京公網安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
广宁县| 红安县| 青阳县| 十堰市| 贵溪市| 敦化市| 五河县| 唐海县| 遂宁市| 钟祥市| 吴江市| 衡东县| 玛沁县| 公主岭市| 凤凰县| 吕梁市| 扶绥县| 曲松县| 怀来县| 定南县| 海丰县| 息烽县| 华阴市| 宜川县| 眉山市| 瑞丽市| 区。| 米易县| 芦山县| 上栗县| 辽源市| 阿拉善左旗| 沁源县| 昌平区| 工布江达县| 平罗县| 莆田市| 奎屯市| 嫩江县| 丘北县| 巴彦县|